Capturing acute toxicity data during lung radiotherapy by using a patient-reported assessment tool

Clinical Lung Cancer

Volumn 14, Issue 2, 2013, Pages 108-112

  Tang, Brooke ^a   Giuliani, Meredith ^a   Le, Lisa W ^a   Higgins, Jane ^a   Bezjak, Andrea ^a   Brade, Anthony ^a   Cho, B C John ^a   Sun, Alexander ^a   Hope, Andrew J ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Acute toxicity; CTCAE; Lung cancer; Patient reported outcomes

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT TOOL; COUGHING; DYSPHAGIA; DYSPNEA; FEASIBILITY STUDY; FEMALE; HEMOPTYSIS; HUMAN; INSOMNIA; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; NAUSEA; ODYNOPHAGIA; RADIATION INJURY; RATING SCALE; SELF REPORT; SKIN DISEASE; THORACIC SYMPTOM SELF ASSESSMENT TOOL; THORAX PAIN; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY; SELF-ASSESSMENT;

EID: 84875272850     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2012.06.003     Document Type: Article

References (20)

1. C.G. Varricchio, J.A. Sloan The need for and characteristics of randomized, phase III trials to evaluate symptom management in patients with cancer J Natl Cancer Inst 94 2002 1184 1185
2. E.K. Fromme, K.M. Eilers, M. Mori How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the quality-of-life questionnaire J Clin Oncol 22 2004 3485 3490 C30
3. D.P. Dearnaley, M.R. Sydes, R.E. Langley The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397) Radiother Oncol 83 2007 31 41
4. G.M. Freedman, P.R. Anderson, L.J. Goldstein Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost Int J Radiat Oncol Biol Phys 68 2007 347 353
5. M.L. Luoma, L. Hakamies-Blomqvist, J. Sjöström Physical performance, toxicity, and quality of life as assessed by the physician and the patient Acta Oncol 41 2002 44 49
6. B. Movsas, C. Scott, C. Langer Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01 J Clin Oncol 23 2005 2145 2154
7. H.K. Tsai, J. Manola, A. Abner Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy Urol Oncol 23 2005 230 237
8. S.M. Bentzen, L.S. Constine, J.O. Deasy Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues Int J Radiat Oncol Biol Phys 76 2010 S3 S9
9. A. Meirovitz, C.A. Murdoch-Kinch, M. Schipper Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer Int J Radiat Oncol Biol Phys 66 2006 445 453
10. L. Sarna, S. Swann, C. Langer Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801 Int J Radiat Oncol Biol Phys 72 2008 1378 1384
11. I.D. Schnadig, E.K. Fromme, C.L. Loprinzi Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer Cancer 113 2008 2205 2214
12. E. Basch, A. Iasonos, T. McDonough Patient versus clinician symptom reporting using the National Cancer Institute common terminology criteria for adverse events: results of a questionnaire-based study Lancet Oncol 7 2006 903 909
13. N.J. Vogelzang, W. Breitbart, D. Cella Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey The Fatigue Coalition Semin Hematol 34 1997 4 12
14. A. Trotti, A.D. Colevas, A. Setser CTCAE 3.0: development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181
15. K.F. Ho, D.J. Farnell, J.A. Routledge Developing a CTCAEs patient questionnaire for late toxicity after head and neck radiotherapy Eur J Cancer 45 2009 1992 1998
16. T. Rosewall, J. Yan, A.J. Bayley Inter-professional variability in the assignment and recording of acute toxicity grade using the RTOG system during prostate radiotherapy Radiother Oncol 90 2009 395 399
17. D.V. Cicchetti, T. Allison A new procedure for assessing reliability of scoring EEG sleep recordings Am J EEG Technol 11 1971 101 109
18. J.R. Landis, G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
19. V.R. Feinstein Principle of Medical Statistics 2001 Chapman and Hall/CRC
20. E. Basch Patient-reported outcomes version of the CTCAE (PRO-CTCAE) [the National Cancer Institute Web site] https://wiki.nci.nih.gov/display/PROCTCAE/ Patient-Reported+Outcomes+version+of+the+CTCAE+%28PRO-CTCAE%29 Accessed: April 9, 2010